Comstock Inc. LODE Bioleum — Nonoperating Income Expense

Other segment segments

Similar metrics at other companies

ANABBiopharma Company — Nonoperating Income Expense

$2.33M-43.0%

ANABBiopharma Company — Other Nonoperating Income Expense

-$1K+85.7%

PFEBiopharma — Other Nonoperating Income (Expense)

$116M+48.7%

UFPIAll Other Segments — Nonoperating Income Expense

$1.82M+92.2%

INSPOperating Segment — Nonoperating Income (Expense)

$3.52M-37.7%

ASSTCorporate & Other — Nonoperating Income (Expense)

$47.03M—

Questions, answered.

What is Comstock Inc.'s bioleum — nonoperating income expense?

Comstock Inc. (LODE) reported bioleum — nonoperating income expense of -$30.95K in Q1 2026.

How has Comstock Inc.'s bioleum — nonoperating income expense changed year-over-year?

Comstock Inc.'s bioleum — nonoperating income expense increased by 59.9% year-over-year, from -$77.1K to -$30.95K.

What does bioleum — nonoperating income expense mean?

Includes financial items outside the scope of the Bioleum segment's primary business activities, such as interest income, investment gains, or other miscellaneous non-core items. This metric helps isolate the impact of peripheral financial activities on the segment's bottom line.